Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE3B | Q13370 | 1/20 | 0.35 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15145687 | 0.83 | ADORA3 (0.36) | ALDH1A1LMNA | |
| SCHEMBL630795 | 0.81 | KDM4E (0.42) | ALDH1A1 | |
| SCHEMBL30575282 | 0.81 | KDM4E (0.42) | ALDH1A1 | |
| SCHEMBL277948 | 0.79 | PDE3B (0.45) | PDE3BPDE3AALDH1A1NPC1RAB9A | |
| SCHEMBL28285903 | 0.79 | YTHDC1 (0.33) | ALDH1A1NPC1RAB9ALMNA | |
| SCHEMBL20839005 | 0.74 | MAPT (0.46) | ALDH1A1NPC1 | |
| SCHEMBL23602966 | 0.71 | PDE3B (0.38) | PDE3BPDE3AALDH1A1NPC1RAB9A | |
| SCHEMBL3701660 | 0.71 | PDE3B (0.38) | PDE3BPDE3AALDH1A1NPC1RAB9A | |
| SCHEMBL29434463 | 0.71 | PDE3B (0.38) | PDE3BPDE3AALDH1A1NPC1RAB9A | |
| SCHEMBL17249596 | 0.71 | NAPRT (0.43) | ALDH1A1NPC1RAB9ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023171697-A1 | PRODUCTION METHOD FOR FLUORINE-CONTAINING COMPOUND | ＡＧＣ株式会社 | 2023-09-14 | — | — | WO | disclosed |
| WO-2023171697-A1 | PRODUCTION METHOD FOR FLUORINE-CONTAINING COMPOUND | ＡＧＣ株式会社 | 2023-09-14 | — | — | WO | disclosed |
| US-20090233934-A1 | Pyrazinecarboxamide Derivatives and Plant Disease Controlling Agents Containing the Same | NIHON NOHYAKU CO., LTD. (JP) | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090233934-A1 | Pyrazinecarboxamide Derivatives and Plant Disease Controlling Agents Containing the Same | CBR3, CNPY2, AADAC | PDE3B 3947/4885PDE3A 3440/4885ALDH1A1 3219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.